Central Bank & Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-53
Closed -$10.4K 219
2024
Q2
$10.4K Hold
53
﹤0.01% 312
2024
Q1
$11.4K Hold
53
﹤0.01% 289
2023
Q4
$11.2K Hold
53
﹤0.01% 302
2023
Q3
$10.6K Buy
+53
New +$10.5K ﹤0.01% 282
2017
Q2
Sell
-122
Closed -$14K 282
2017
Q1
$14K Sell
122
-122
-50% -$14.7K ﹤0.01% 245
2016
Q4
$28K Hold
244
0.01% 220
2016
Q3
$26K Hold
244
0.01% 213
2016
Q2
$24K Hold
244
0.01% 218
2016
Q1
$23K Sell
244
-21
-8% -$1.91K 0.01% 223
2015
Q4
$24K Sell
265
-42
-14% -$3.95K 0.01% 229
2015
Q3
$28K Buy
307
+243
+380% +$23.1K 0.01% 229
2015
Q2
$6K Buy
+64
New +$5.97K ﹤0.01% 310

Other funds holding CME

Central Bank & Trust's CME Position: Q3 2024 in Review

Central Bank & Trust sold out of CME Group (CME) in Q3 2024, closing a stake of 53 shares — an estimated $10.4K sold.

Central Bank & Trust first reported a position in CME in Q2 2015 and held it in 12 quarters. The position peaked at $28K in Q4 2016. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • Central Bank & Trust reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
  • Central Bank & Trust sold 53 CME Group shares in Q3 2024, an estimated $10.4K.
  • Central Bank & Trust first reported a position in CME Group in Q2 2015 and held it in 12 quarters.
  • Central Bank & Trust's CME Group position peaked at $28K in Q4 2016.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Central Bank & Trust's 13F filing for Q3 2024, filed 30 Oct 2024.